Paid-Up License. Upon expiration of Amgen's obligation hereunder to pay a Royalty on Net Sales of a Compound in a country, Amgen shall have a fully paid unrestricted license to make, use and sell such Compound in the Field of Use in that country.
Appears in 1 contract
Samples: Confidential Treatment Requested (NPS Pharmaceuticals Inc)
Paid-Up License. Upon the expiration of Amgen's obligation hereunder under this Article 8 to pay a Royalty royalties on Net Sales of a Compound Product in a country, Amgen shall have a fully paid unrestricted license paid-up, non-exclusive license, with the right to sublicense, to make, use and have made, use, sell, lease, offer to sell or lease, import, export or otherwise exploit, transfer physical possession of or otherwise transfer title in such Compound Product in the Field of Use in that country.
Appears in 1 contract
Paid-Up License. Upon the expiration of Amgen's ’s obligation hereunder under this Article 8 to pay a Royalty royalties on Net Sales of a Compound Product in a country, Amgen shall have a fully paid unrestricted license paid-up, non-exclusive license, with the right to sublicense, to make, use and have made, use, sell, lease, offer to sell or lease, import, export or otherwise exploit, transfer physical possession of or otherwise transfer title in such Compound Product in the Field of Use in that country.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Genome Therapeutics Corp)
Paid-Up License. Upon the expiration of Amgen's obligation hereunder --------------- pursuant to Section 5.6.1 to pay a Royalty Royalties on Net Sales of a Compound Product in a country, Amgen shall have a fully paid unrestricted paid-up, unrestricted, non-exclusive license under Licensed Technology to make, use have made, use, sell, offer to sell and sell such Compound import said Product in the Field of Use in that country.
Appears in 1 contract
Samples: Research and Commercialization Agreement (Medarex Inc)